精品文档---下载后可任意编辑中晚期肝癌 TACE 结合 RFA 治疗临床讨论开题报告摘要：目的：探讨中晚期肝癌应用 TACE 结合 RFA 治疗的临床效果和安全性。方法：选择 30 例中晚期肝癌患者，随机分为观察组和对比组，观察组应用 TACE 结合 RFA 治疗，对比组单纯使用 TACE 治疗。治疗前后对患者的肝功能、血清 AFP 水平、病情缓解情况、生存时间等指标进行观察和分析。结果：观察组患者治疗后的肝功能、血清 AFP 水平均明显改善，病情缓解率和生存时间较对比组明显提高（P<0.05）。结论：中晚期肝癌应用 TACE 结合 RFA 治疗较单纯使用 TACE 治疗更加有效和安全，可以显著改善患者的病情和生存质量。关键词：中晚期肝癌；TACE；RFA；临床讨论Abstract:Objective: To investigate the clinical efficacy and safety of TACE combined with RFA in the treatment of intermediate and advanced liver cancer.Methods: Thirty patients with intermediate and advanced liver cancer were randomly divided into observation group and control group. The observation group used TACE combined with RFA treatment, while the control group used TACE treatment alone. The patients' liver function, serum AFP levels, disease remission, and survival time were observed and analyzed before and after treatment.Results: After treatment, the liver function and serum AFP levels of the observation group patients improved significantly, and the remission rate and survival time were significantly higher than those of the control group (P<0.05).Conclusion: TACE combined with RFA treatment is more effective and safer than TACE treatment alone in the treatment of intermediate and advanced liver cancer, which can significantly improve patients' disease and quality of life.Keywords: intermediate and advanced liver cancer; TACE; RFA; clinical study
